Dermira, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Menlo Park CA United States (2010)
Status: Acquired by Eli Lilly (2020)

Organization Overview

First Clinical Trial
2011
NCT01490736
First Marketed Drug
2018
glycopyrronium (robinul)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dermira, Inc. | DERMIRA INC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Dermatitis (Phase 3)

Dermatitis, Atopic (Phase 3)

Eczema (Phase 3)

Hyperhidrosis (Phase 3)

Psoriasis (Phase 3)

Rosacea (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 25
  • # of Trial APIs: 7